These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29657696)

  • 1. Comparing Effectiveness of Mindfulness-Based Relapse Prevention with Treatment as Usual on Impulsivity and Relapse for Methadone-Treated Patients: A Randomized Clinical Trial.
    Yaghubi M; Zargar F; Akbari H
    Addict Health; 2017 Jul; 9(3):156-165. PubMed ID: 29657696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.
    Bowen S; Witkiewitz K; Clifasefi SL; Grow J; Chawla N; Hsu SH; Carroll HA; Harrop E; Collins SE; Lustyk MK; Larimer ME
    JAMA Psychiatry; 2014 May; 71(5):547-56. PubMed ID: 24647726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study.
    Zullig KJ; Lander LR; Tuscano M; Garland M; Hobbs GR; Faulkenberry L
    Mindfulness (N Y); 2021; 12(12):3036-3046. PubMed ID: 34659584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Mindfulness-based Relapse Prevention on Quality of Life and Craving in Methadone-treated Patients: A Randomized Clinical Trial.
    Yaghubi M; Zargar F
    Addict Health; 2018 Oct; 10(4):250-259. PubMed ID: 31263524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine use disorder: Study protocol for a randomized controlled trial.
    Chen XJ; Wang DM; Zhou LD; Winkler M; Pauli P; Sui N; Li YH
    Contemp Clin Trials; 2018 Jul; 70():99-105. PubMed ID: 29679670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use outcomes for mindfulness based relapse prevention are partially mediated by reductions in stress: Results from a randomized trial.
    Davis JP; Berry D; Dumas TM; Ritter E; Smith DC; Menard C; Roberts BW
    J Subst Abuse Treat; 2018 Aug; 91():37-48. PubMed ID: 29910013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for a randomized controlled trial of mindfulness-based relapse prevention for opioid use disorders.
    Zinzow H; Shi L; Rennert L; Chen L; Lopes S; Zhang L; Jones K; Jindal M; Stam C; Mclain M
    Contemp Clin Trials; 2020 Dec; 99():106182. PubMed ID: 33080378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mindfulness-based relapse prevention for cannabis regular users: Preliminary outcomes of a randomized clinical trial.
    Schneegans A; Bourgognon F; Albuisson E; Schwan R; Arfa M; Polli L; Moulard M; Laprévote V; Schwitzer T
    Encephale; 2022 Jun; 48(3):241-246. PubMed ID: 34092381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mindfulness on decision-making, inhibitory control, and impulsivity of substance use disorder in-treatment patients: A randomized clinical trial.
    Donate APG; de Macedo EC; Bedendo A; Félix Júnior I; Gallo GG; Opaleye ES; Noto AR
    PLoS One; 2023; 18(11):e0293502. PubMed ID: 37934743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mindfulness-based relapse prevention for alcohol dependence: Findings from a randomized controlled trial.
    Zgierska AE; Burzinski CA; Mundt MP; McClintock AS; Cox J; Coe CL; Miller MM; Fleming MF
    J Subst Abuse Treat; 2019 May; 100():8-17. PubMed ID: 30898331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mindfulness-based-relapse prevention (MBRP): Evaluation of the impact of a group of Mindfulness Therapy in alcohol relapse prevention for alcohol use disorders].
    Carpentier D; Romo L; Bouthillon-Heitzmann P; Limosin F
    Encephale; 2015 Dec; 41(6):521-6. PubMed ID: 26159682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of mindfulness-based relapse prevention in a sample of veterans in a substance use disorder aftercare program: A randomized controlled trial.
    Killeen TK; Baker NL; Davis LL; Bowen S; Brady KT
    J Subst Use Addict Treat; 2023 Sep; 152():209116. PubMed ID: 37364669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Mindfulness-Based Relapse Prevention Program as an Adjunct to the Standard Treatment for Smoking: A Pragmatic Design Pilot Study.
    Weiss de Souza IC; Kozasa EH; Bowen S; Richter KP; Sartes LMA; Colugnati FAB; Noto AR
    Nicotine Tob Res; 2020 Aug; 22(9):1605-1613. PubMed ID: 32222767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Mindfulness-Based Relapse Prevention on Impulsivity Trajectories Among Young Adults in Residential Substance Use Disorder Treatment.
    Davis JP; Barr N; Dworkin ER; Dumas TM; Berey B; DiGuiseppi G; Rael Cahn B
    Mindfulness (N Y); 2019 Oct; 10(10):1997-2009. PubMed ID: 32595783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of mindfulness-based relapse prevention for compulsive sexual behaviour disorder.
    Holas P; Draps M; Kowalewska E; Lewczuk K; Gola M
    J Behav Addict; 2020 Nov; 9(4):1088-1092. PubMed ID: 33216012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial.
    Skrzynski CJ; Karoly H; Ellingson JM; Hagerty SL; Bryan AD; Hutchison KE
    J Stud Alcohol Drugs; 2023 Jul; 84(4):560-569. PubMed ID: 36971735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mindfulness Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial.
    Glasner-Edwards S; Mooney LJ; Ang A; Garneau HC; Hartwell E; Brecht ML; Rawson RA
    Mindfulness (N Y); 2017 Feb; 8(1):126-135. PubMed ID: 28191264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mindfulness-based relapse prevention in veterans with substance use disorders: Design and methodology of a randomized clinical trial.
    Brady KT; Killeen T; Baker NL
    Contemp Clin Trials; 2021 Jun; 105():106393. PubMed ID: 33857680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention.
    Witkiewitz K; Bowen S
    J Consult Clin Psychol; 2010 Jun; 78(3):362-374. PubMed ID: 20515211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility, acceptability and preliminary outcomes of a mindfulness-based relapse prevention program in a naturalistic setting among treatment-seeking patients with alcohol use disorder: a prospective observational study.
    von Hammerstein C; Khazaal Y; Dupuis M; Aubin HJ; Benyamina A; Luquiens A; Romo L
    BMJ Open; 2019 Jun; 9(5):e026839. PubMed ID: 31154307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.